KHO THƯ VIỆN 🔎

Efficacy of chaox1 ncov19 vaccice against sarv cov 2

➤  Gửi thông báo lỗi    ⚠️ Báo cáo tài liệu vi phạm

Loại tài liệu:     PDF
Số trang:         40 Trang
Tài liệu:           ✅  ĐÃ ĐƯỢC PHÊ DUYỆT
 













Nội dung chi tiết: Efficacy of chaox1 ncov19 vaccice against sarv cov 2

Efficacy of chaox1 ncov19 vaccice against sarv cov 2

Efficacy of ChAdOxl nCoV-19 (AZD1222) vaccine against SARS-CoV-2 voc 202012/01 (B.1.1.7)Katherine R. w. Emary1*, Tanya Golubchik13 *. ParvinderK. Aley

Efficacy of chaox1 ncov19 vaccice against sarv cov 2 y1. Cristina V.Ariani29, Brian Angus2. Sagida Bibi1. Beth Blane-’’. David Bonsall4. Paola Cicconi2. Sue Charlton-. Elizabeth A. Clutterbuck1, Andrea M

. Collins7. Tony Cox*, Thomas c. Darton’,Christina Dold1, Alexander [). Douglas2, Christopher J. A. Duncan10, Katie J. Ewer2. Amy Flaxman2, Saul N. Fa Efficacy of chaox1 ncov19 vaccice against sarv cov 2

ust11, Daniela M. Ferreira’, Shuo Feng1. Adam Finn12. Pedro M. Folegatti2 Michelle Fuskova2. Eva Galiza14, Anna L. Goodman1*, Catherine M. Green5. Chr

Efficacy of chaox1 ncov19 vaccice against sarv cov 2

istopher A. Green15. Melanie Greenland1. Bassam Hallis3. Paul T. Heath14. Jodie Hay14. Helen c. Hili’, Daniel Jenkin2. Simon Kerridge1. Rajeka Lazarus

Efficacy of ChAdOxl nCoV-19 (AZD1222) vaccine against SARS-CoV-2 voc 202012/01 (B.1.1.7)Katherine R. w. Emary1*, Tanya Golubchik13 *. ParvinderK. Aley

Efficacy of chaox1 ncov19 vaccice against sarv cov 2 1. Daniel J. Phillips1. Emma Plested1. Katrina M. Pollock -'. Hannah Robinson1. Andrew Smith-’. Rinn Song1. Matthew D. Snape1. Rebecca K. Sutherland2*

. Emma c. Thomson-'*, Mark Toshner24, David p. J. Turner2’, Johan Vekemans*, Tonya L. Villafana4. Christopher J Williams25. Adrian V. s Hill2*. Teresa Efficacy of chaox1 ncov19 vaccice against sarv cov 2

Lambe2*, Sarah c. Gilbert2*, Merryn Voysey1*, Maheshi N. Ramasamy1*, Andrew J Pollard1* . The COVID-19 Genomics UK (COG-UK) consortium 29 and the Oxf

Efficacy of chaox1 ncov19 vaccice against sarv cov 2

ord COVID Vaccine Trial Group.Contributed Equally1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK: A. J.Pollard FMedSci. M.

Efficacy of ChAdOxl nCoV-19 (AZD1222) vaccine against SARS-CoV-2 voc 202012/01 (B.1.1.7)Katherine R. w. Emary1*, Tanya Golubchik13 *. ParvinderK. Aley

Efficacy of chaox1 ncov19 vaccice against sarv cov 2 , N.G. Marchevsky MSc. Y. F Mujadidi MSc. D. J. Phillips MMath. E. Plested. M. N. Ramasamy DPhil. H Robinson RN. M. D. Snape MD, R. Song MD2Jenner Ins

titute. Nuffield Department of Medicine, University of Oxford, UK: A. D. Douglas DPhil, A. Flaxman DPhil. S. C. Gilbert PhD. T. Lambe PhD. A. V. S. Hi Efficacy of chaox1 ncov19 vaccice against sarv cov 2

ll FMedSci. p. M. Folegatti MD. B.This preprint research paper has not been peer reviewed. Electronic copy available at: https://ssm.com/abstract=3779

Efficacy of chaox1 ncov19 vaccice against sarv cov 2

160Angus MD. p. Cicconi MD P11D. K.J. Ewer PhD. M. Fuskova MSc. D. Jenkin MRCP. A. M. Minassian DPhil1 National Infection Service. Public Health Engla

Efficacy of ChAdOxl nCoV-19 (AZD1222) vaccine against SARS-CoV-2 voc 202012/01 (B.1.1.7)Katherine R. w. Emary1*, Tanya Golubchik13 *. ParvinderK. Aley

Efficacy of chaox1 ncov19 vaccice against sarv cov 2 University of Oxford, UK: c. M. Green PhD6 Wellcome Centre for I Inman Genetics. Nuffield Department of Medicine. University of Oxford. UK: D. Bonsal

l PhD"Department of Clinical Sciences. I iverpool School of Tropical Medicine and I iverpool University Hospitals Nils Foundation Trust: A. M. Collins Efficacy of chaox1 ncov19 vaccice against sarv cov 2

PhD. I). M. Ferreira PhD. II. c. Hill PhD■ UK Biocentre. Units 2 & 3. Java Park. Bradboume Drive. Tilbrook. UK: T. Cox OBE. PhD9 Department of Infect

Efficacy of chaox1 ncov19 vaccice against sarv cov 2

ion, Immunity and Cardiovascular Disease, University of Sheffield and Department of Infection and Tropical Medicine. Sheffield Teaching Hospitals NHS

Efficacy of ChAdOxl nCoV-19 (AZD1222) vaccine against SARS-CoV-2 voc 202012/01 (B.1.1.7)Katherine R. w. Emary1*, Tanya Golubchik13 *. ParvinderK. Aley

Efficacy of chaox1 ncov19 vaccice against sarv cov 2 anslational and Clinical Research Institute, Immunity and Inflammation Theme.Newcastle University: c. J. A. Duncan DPhiln NIHR Southampton Clinical Re

search Facility and Biomedical Research Centre. University Hospital Southampton Nils Foundation Trust, and Faculty of Medicine and Institute for Life Efficacy of chaox1 ncov19 vaccice against sarv cov 2

Sciences. University of Southampton. Southampton. UK: s. N. Faust PhD: ■' University Hospitals Bristol and Weston NHS Foundation Trust. UK: A. Finn FR

Efficacy of chaox1 ncov19 vaccice against sarv cov 2

CPCHBig Data Institute. Nuffield Department of Medicine. University of Oxford. UK: I . Goluhchik PhDIIDepartment of Infection, Guy’s and St Thomas’ Nl

Efficacy of ChAdOxl nCoV-19 (AZD1222) vaccine against SARS-CoV-2 voc 202012/01 (B.1.1.7)Katherine R. w. Emary1*, Tanya Golubchik13 *. ParvinderK. Aley

Efficacy of chaox1 ncov19 vaccice against sarv cov 2 Wellcome Trust Clinical Research Facility. University Hospitals Birmingham NHS Foundation Trust. Birmingham. UK: c. A. Green DPhilreviewe216St George'

s Vaccine Institute, St George's, University of London, UK: E. Galiza MDBS, p. T. Heath FRCPCH17University of Glasgow. Glasgow, UK and Lighthouse Labo Efficacy of chaox1 ncov19 vaccice against sarv cov 2

ratory in Glasgow, Queen Elizabeth University Hospital. Glasgow. UK: J. Hay PhD15 Severn Pathology. North Bristol NHS Trust: R. Lazarus DPhil19NIHR UC

Efficacy of chaox1 ncov19 vaccice against sarv cov 2

LH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London. UK: V. Libri MD FRCP20Hull University Teaching Hospitals NHS Trust. UK

Efficacy of ChAdOxl nCoV-19 (AZD1222) vaccine against SARS-CoV-2 voc 202012/01 (B.1.1.7)Katherine R. w. Emary1*, Tanya Golubchik13 *. ParvinderK. Aley

Efficacy of chaox1 ncov19 vaccice against sarv cov 2 rial Biomedical Research Centre. London. UK: K. M. Pollock PhD22College of Medical, Veterinary & Life Sciences. Glasgow Dental Hospital & School. Univ

ersity of Glasgow: A. Smith FRCPath24 Clinical Infection Research Group. Regional Infectious Diseases Unit, Western General Hospital. Edinburgh. UK: R Efficacy of chaox1 ncov19 vaccice against sarv cov 2

. K. Sutherland FRCP

Efficacy of ChAdOxl nCoV-19 (AZD1222) vaccine against SARS-CoV-2 voc 202012/01 (B.1.1.7)Katherine R. w. Emary1*, Tanya Golubchik13 *. ParvinderK. Aley

Efficacy of ChAdOxl nCoV-19 (AZD1222) vaccine against SARS-CoV-2 voc 202012/01 (B.1.1.7)Katherine R. w. Emary1*, Tanya Golubchik13 *. ParvinderK. Aley

Gọi ngay
Chat zalo
Facebook